[24] The oncological outcome of robot-assisted partial nephrectomy in the treatment of renal cell carcinomas

Objective: To report on our oncological outcomes of robot-assisted partial nephrectomy (RPN) in the treatment of renal cell carcinoma (RCC) by a single surgeon in a single institute, as RPN has an established role in the treatment of RCC with an oncological outcome comparable to open surgery. Method...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mohamad Salkini, Abdulraof Lamoshi
Formato:	article
Lenguaje:	EN
Publicado:	Taylor & Francis Group 2018
Materias:	Diseases of the genitourinary system. Urology RC870-923
Acceso en línea:	https://doaj.org/article/db5d914190e94398bc86f9be09941caf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:db5d914190e94398bc86f9be09941caf
record_format	dspace
spelling	oai:doaj.org-article:db5d914190e94398bc86f9be09941caf2021-12-02T10:11:41Z[24] The oncological outcome of robot-assisted partial nephrectomy in the treatment of renal cell carcinomas2090-598X10.1016/j.aju.2018.10.071https://doaj.org/article/db5d914190e94398bc86f9be09941caf2018-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2090598X18301657https://doaj.org/toc/2090-598XObjective: To report on our oncological outcomes of robot-assisted partial nephrectomy (RPN) in the treatment of renal cell carcinoma (RCC) by a single surgeon in a single institute, as RPN has an established role in the treatment of RCC with an oncological outcome comparable to open surgery. Methods: We reviewed prospectively collected data of patients who underwent RPN with a final diagnosis of RCC. RPN was used routinely in the treatment of small renal masses (<4 cm) and selectively in the treatment of larger masses (4–7 cm) at our institute. RPN was performed according to the standard protocol with a variable ischaemia time of 0–34 min. All the specimens were placed in an EndoCatch™ single-use specimen pouch. Results: In all, 335 patients underwent RPN at our institute by a single surgeon, with RCC the final diagnosis in 269 patients (80.3%). All patients but two (0.74%) had a negative margin at the initial surgery. Nine patients (3.3%) had recurrence of the RCC with a different modality of recurrence. Two patients had trocar-site recurrence, two had loco-regional recurrence with infiltration of the disease in the perinephric fat and lymph nodes, three had recurrence of the disease at the resection margin, and two had a second primary tumour in the other kidney. On multi- and univariable analyses, the tumour grade (Grade > 3), tumour stage (T1b, or T3) and tumour size (>4 cm) were associated with the likelihood of recurrence except trocar-site recurrence. Conclusion: RPN offers excellent control of RCC as shown by a low risk of recurrence (3.3%). RPN should be considered as the treatment of choice whenever it is feasible. Larger tumours, higher stage and local invasion are surrogates for recurrence.Mohamad SalkiniAbdulraof LamoshiTaylor & Francis GrouparticleDiseases of the genitourinary system. UrologyRC870-923ENArab Journal of Urology, Vol 16, Iss , Pp S12- (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the genitourinary system. Urology RC870-923
spellingShingle	Diseases of the genitourinary system. Urology RC870-923 Mohamad Salkini Abdulraof Lamoshi [24] The oncological outcome of robot-assisted partial nephrectomy in the treatment of renal cell carcinomas
description	Objective: To report on our oncological outcomes of robot-assisted partial nephrectomy (RPN) in the treatment of renal cell carcinoma (RCC) by a single surgeon in a single institute, as RPN has an established role in the treatment of RCC with an oncological outcome comparable to open surgery. Methods: We reviewed prospectively collected data of patients who underwent RPN with a final diagnosis of RCC. RPN was used routinely in the treatment of small renal masses (<4 cm) and selectively in the treatment of larger masses (4–7 cm) at our institute. RPN was performed according to the standard protocol with a variable ischaemia time of 0–34 min. All the specimens were placed in an EndoCatch™ single-use specimen pouch. Results: In all, 335 patients underwent RPN at our institute by a single surgeon, with RCC the final diagnosis in 269 patients (80.3%). All patients but two (0.74%) had a negative margin at the initial surgery. Nine patients (3.3%) had recurrence of the RCC with a different modality of recurrence. Two patients had trocar-site recurrence, two had loco-regional recurrence with infiltration of the disease in the perinephric fat and lymph nodes, three had recurrence of the disease at the resection margin, and two had a second primary tumour in the other kidney. On multi- and univariable analyses, the tumour grade (Grade > 3), tumour stage (T1b, or T3) and tumour size (>4 cm) were associated with the likelihood of recurrence except trocar-site recurrence. Conclusion: RPN offers excellent control of RCC as shown by a low risk of recurrence (3.3%). RPN should be considered as the treatment of choice whenever it is feasible. Larger tumours, higher stage and local invasion are surrogates for recurrence.
format	article
author	Mohamad Salkini Abdulraof Lamoshi
author_facet	Mohamad Salkini Abdulraof Lamoshi
author_sort	Mohamad Salkini
title	[24] The oncological outcome of robot-assisted partial nephrectomy in the treatment of renal cell carcinomas
title_short	[24] The oncological outcome of robot-assisted partial nephrectomy in the treatment of renal cell carcinomas
title_full	[24] The oncological outcome of robot-assisted partial nephrectomy in the treatment of renal cell carcinomas
title_fullStr	[24] The oncological outcome of robot-assisted partial nephrectomy in the treatment of renal cell carcinomas
title_full_unstemmed	[24] The oncological outcome of robot-assisted partial nephrectomy in the treatment of renal cell carcinomas
title_sort	[24] the oncological outcome of robot-assisted partial nephrectomy in the treatment of renal cell carcinomas
publisher	Taylor & Francis Group
publishDate	2018
url	https://doaj.org/article/db5d914190e94398bc86f9be09941caf
work_keys_str_mv	AT mohamadsalkini 24theoncologicaloutcomeofrobotassistedpartialnephrectomyinthetreatmentofrenalcellcarcinomas AT abdulraoflamoshi 24theoncologicaloutcomeofrobotassistedpartialnephrectomyinthetreatmentofrenalcellcarcinomas
_version_	1718397541597315072

[24] The oncological outcome of robot-assisted partial nephrectomy in the treatment of renal cell carcinomas

Ejemplares similares